THE ADDITION OF CETUXIMAB TO OXALIPLATIN-FLUOROPYRIMIDINE CHEMOTHERAPY IN FIRST-LINE ADVANCED COLORECTAL CANCER IN THE MRC COIN TRIAL: IDENTIFICATION OF POTENTIALLY RESPONSIVE SUBSETS OF PATIENTS

Bibliographic Details
Main Authors: Maughan, T, Adams, R, Smith, C, Seymour, M, Wilson, R, Meade, A, Fisher, D, Madi, A, Cheadle, J, Kaplan, R
Format: Conference item
Published: 2010
_version_ 1826275358281826304
author Maughan, T
Adams, R
Smith, C
Seymour, M
Wilson, R
Meade, A
Fisher, D
Madi, A
Cheadle, J
Kaplan, R
author_facet Maughan, T
Adams, R
Smith, C
Seymour, M
Wilson, R
Meade, A
Fisher, D
Madi, A
Cheadle, J
Kaplan, R
author_sort Maughan, T
collection OXFORD
description
first_indexed 2024-03-06T22:57:30Z
format Conference item
id oxford-uuid:60efec80-f2dd-447d-be50-92a04a155c6b
institution University of Oxford
last_indexed 2024-03-06T22:57:30Z
publishDate 2010
record_format dspace
spelling oxford-uuid:60efec80-f2dd-447d-be50-92a04a155c6b2022-03-26T17:56:24ZTHE ADDITION OF CETUXIMAB TO OXALIPLATIN-FLUOROPYRIMIDINE CHEMOTHERAPY IN FIRST-LINE ADVANCED COLORECTAL CANCER IN THE MRC COIN TRIAL: IDENTIFICATION OF POTENTIALLY RESPONSIVE SUBSETS OF PATIENTSConference itemhttp://purl.org/coar/resource_type/c_5794uuid:60efec80-f2dd-447d-be50-92a04a155c6bSymplectic Elements at Oxford2010Maughan, TAdams, RSmith, CSeymour, MWilson, RMeade, AFisher, DMadi, ACheadle, JKaplan, R
spellingShingle Maughan, T
Adams, R
Smith, C
Seymour, M
Wilson, R
Meade, A
Fisher, D
Madi, A
Cheadle, J
Kaplan, R
THE ADDITION OF CETUXIMAB TO OXALIPLATIN-FLUOROPYRIMIDINE CHEMOTHERAPY IN FIRST-LINE ADVANCED COLORECTAL CANCER IN THE MRC COIN TRIAL: IDENTIFICATION OF POTENTIALLY RESPONSIVE SUBSETS OF PATIENTS
title THE ADDITION OF CETUXIMAB TO OXALIPLATIN-FLUOROPYRIMIDINE CHEMOTHERAPY IN FIRST-LINE ADVANCED COLORECTAL CANCER IN THE MRC COIN TRIAL: IDENTIFICATION OF POTENTIALLY RESPONSIVE SUBSETS OF PATIENTS
title_full THE ADDITION OF CETUXIMAB TO OXALIPLATIN-FLUOROPYRIMIDINE CHEMOTHERAPY IN FIRST-LINE ADVANCED COLORECTAL CANCER IN THE MRC COIN TRIAL: IDENTIFICATION OF POTENTIALLY RESPONSIVE SUBSETS OF PATIENTS
title_fullStr THE ADDITION OF CETUXIMAB TO OXALIPLATIN-FLUOROPYRIMIDINE CHEMOTHERAPY IN FIRST-LINE ADVANCED COLORECTAL CANCER IN THE MRC COIN TRIAL: IDENTIFICATION OF POTENTIALLY RESPONSIVE SUBSETS OF PATIENTS
title_full_unstemmed THE ADDITION OF CETUXIMAB TO OXALIPLATIN-FLUOROPYRIMIDINE CHEMOTHERAPY IN FIRST-LINE ADVANCED COLORECTAL CANCER IN THE MRC COIN TRIAL: IDENTIFICATION OF POTENTIALLY RESPONSIVE SUBSETS OF PATIENTS
title_short THE ADDITION OF CETUXIMAB TO OXALIPLATIN-FLUOROPYRIMIDINE CHEMOTHERAPY IN FIRST-LINE ADVANCED COLORECTAL CANCER IN THE MRC COIN TRIAL: IDENTIFICATION OF POTENTIALLY RESPONSIVE SUBSETS OF PATIENTS
title_sort addition of cetuximab to oxaliplatin fluoropyrimidine chemotherapy in first line advanced colorectal cancer in the mrc coin trial identification of potentially responsive subsets of patients
work_keys_str_mv AT maughant theadditionofcetuximabtooxaliplatinfluoropyrimidinechemotherapyinfirstlineadvancedcolorectalcancerinthemrccointrialidentificationofpotentiallyresponsivesubsetsofpatients
AT adamsr theadditionofcetuximabtooxaliplatinfluoropyrimidinechemotherapyinfirstlineadvancedcolorectalcancerinthemrccointrialidentificationofpotentiallyresponsivesubsetsofpatients
AT smithc theadditionofcetuximabtooxaliplatinfluoropyrimidinechemotherapyinfirstlineadvancedcolorectalcancerinthemrccointrialidentificationofpotentiallyresponsivesubsetsofpatients
AT seymourm theadditionofcetuximabtooxaliplatinfluoropyrimidinechemotherapyinfirstlineadvancedcolorectalcancerinthemrccointrialidentificationofpotentiallyresponsivesubsetsofpatients
AT wilsonr theadditionofcetuximabtooxaliplatinfluoropyrimidinechemotherapyinfirstlineadvancedcolorectalcancerinthemrccointrialidentificationofpotentiallyresponsivesubsetsofpatients
AT meadea theadditionofcetuximabtooxaliplatinfluoropyrimidinechemotherapyinfirstlineadvancedcolorectalcancerinthemrccointrialidentificationofpotentiallyresponsivesubsetsofpatients
AT fisherd theadditionofcetuximabtooxaliplatinfluoropyrimidinechemotherapyinfirstlineadvancedcolorectalcancerinthemrccointrialidentificationofpotentiallyresponsivesubsetsofpatients
AT madia theadditionofcetuximabtooxaliplatinfluoropyrimidinechemotherapyinfirstlineadvancedcolorectalcancerinthemrccointrialidentificationofpotentiallyresponsivesubsetsofpatients
AT cheadlej theadditionofcetuximabtooxaliplatinfluoropyrimidinechemotherapyinfirstlineadvancedcolorectalcancerinthemrccointrialidentificationofpotentiallyresponsivesubsetsofpatients
AT kaplanr theadditionofcetuximabtooxaliplatinfluoropyrimidinechemotherapyinfirstlineadvancedcolorectalcancerinthemrccointrialidentificationofpotentiallyresponsivesubsetsofpatients
AT maughant additionofcetuximabtooxaliplatinfluoropyrimidinechemotherapyinfirstlineadvancedcolorectalcancerinthemrccointrialidentificationofpotentiallyresponsivesubsetsofpatients
AT adamsr additionofcetuximabtooxaliplatinfluoropyrimidinechemotherapyinfirstlineadvancedcolorectalcancerinthemrccointrialidentificationofpotentiallyresponsivesubsetsofpatients
AT smithc additionofcetuximabtooxaliplatinfluoropyrimidinechemotherapyinfirstlineadvancedcolorectalcancerinthemrccointrialidentificationofpotentiallyresponsivesubsetsofpatients
AT seymourm additionofcetuximabtooxaliplatinfluoropyrimidinechemotherapyinfirstlineadvancedcolorectalcancerinthemrccointrialidentificationofpotentiallyresponsivesubsetsofpatients
AT wilsonr additionofcetuximabtooxaliplatinfluoropyrimidinechemotherapyinfirstlineadvancedcolorectalcancerinthemrccointrialidentificationofpotentiallyresponsivesubsetsofpatients
AT meadea additionofcetuximabtooxaliplatinfluoropyrimidinechemotherapyinfirstlineadvancedcolorectalcancerinthemrccointrialidentificationofpotentiallyresponsivesubsetsofpatients
AT fisherd additionofcetuximabtooxaliplatinfluoropyrimidinechemotherapyinfirstlineadvancedcolorectalcancerinthemrccointrialidentificationofpotentiallyresponsivesubsetsofpatients
AT madia additionofcetuximabtooxaliplatinfluoropyrimidinechemotherapyinfirstlineadvancedcolorectalcancerinthemrccointrialidentificationofpotentiallyresponsivesubsetsofpatients
AT cheadlej additionofcetuximabtooxaliplatinfluoropyrimidinechemotherapyinfirstlineadvancedcolorectalcancerinthemrccointrialidentificationofpotentiallyresponsivesubsetsofpatients
AT kaplanr additionofcetuximabtooxaliplatinfluoropyrimidinechemotherapyinfirstlineadvancedcolorectalcancerinthemrccointrialidentificationofpotentiallyresponsivesubsetsofpatients